Procter & Gamble Hygiene and Health Care Ltd

- The transcript does not specifically mention any current or planned fundraising initiatives through debt or equity. - A question on inorganic growth opportunities and acquisition strategy was raised, but the management stated that such information is price sensitive and could not be shared. - There is no explicit disclosure regarding any upcoming fundraises through debt or equity in the provided Q&A or presentations. - The company currently has close to Rs. 1000 crore cash on the books, indicating sufficient liquidity at present. - Any future fundraising plans, if any, have not been disclosed publicly in this session.

- Recently announced a capex of Rs. 2000 crore in digestives for exports under a different legal entity (Page 12). - Investment focus includes expanding manufacturing for exports serving multiple markets like Nepal, Bangladesh, Sri Lanka, Philippines, South Africa (Page 9). - Significant ongoing investment in Supply Chain (Supply 3.0) to build end-to-end synchronized, sustainable, resilient supply chain amplified by data analytics, resulting in faster speed to market and reduced carbon emissions (Page 5). - Continuous investments directed towards innovation, brand superiority, and leveraging technology including AI and Machine Learning for distribution and marketing efficiency (Pages 5, 9). - No specific details shared about inorganic growth opportunities or acquisition strategies due to price sensitivity (Page 12). - Capital investments are supported by positive volume growth and improving rural demand, with a “cautiously optimistic” outlook on market growth (Page 7).

- FMCG volume consumption growth is expected to be in the mid-single digits over the next 5-7 years. - Certain underdeveloped categories have the potential for double-digit growth by improving consumer impact and aligning with countries of similar per capita income. - The company aims to drive category growth through awareness, education, availability across price points and channels, and superior value propositions. - Rural economy shows visible green shoots, encouraging continued investment in rural growth via awareness, trial, and distribution. - E-commerce is contributing double-digit growth to overall revenue, with strong momentum in evolving consumer habits and quick commerce formats. - Topline sales grew 12% in the previous fiscal year despite commodity challenges, showing resilience and growth potential. - The business focuses on balanced top-line and bottom-line growth, including expanding margins and funding innovation.

- P&G India aims to grow bottom-line (profits) ahead of topline in the foreseeable future (Page 13). - The company delivered consistent high single-digit sales growth over the past 10 years with cumulative annual profit growth of 13% (Page 8). - Operating profit margin has increased by 550 basis points during the past 10 years (Page 8). - Profit growth continues despite industry headwinds, with recent profit growth at 10% excluding one-time items (Page 7). - The company focuses on premiumization, pricing, and productivity to drive profit growth (Page 7). - Productivity programs delivered savings of over Rs. 105 crore last year (Page 5). - Margins are expected to continue being managed with efforts on top- and bottom-line growth, including EBITDA margins (Page 13).

The provided transcript does not contain any information related to the current or expected order book or pending orders for Procter & Gamble Hygiene and Health Care Limited. The discussion primarily covers topics such as margin evolution, growth benchmarks, sustainability efforts, capex, rural growth, product launches, distribution strategies, ad spends, competitive intensity, supply chain, and market outlook. No details on order books or pending orders were mentioned.